Literature DB >> 30138136

Genetic testing in children and adolescents with intellectual disability.

Nick Bass1, David Skuse2.   

Abstract

PURPOSE OF REVIEW: Investigation for genetic causes of intellectual disability has advanced rapidly in recent years. We review the assessment of copy number variants (CNVs) and the use of next-generation sequencing based assays to identify single nucleotide variation in intellectual disability. We discuss the diagnostic yields that can be expected with the different assays. There is high co-morbidity of intellectual disability and psychiatric disorders. We review the relationship between variants which are pathogenic for intellectual disability and the risk of child and adolescent onset psychiatric disorders. RECENT
FINDINGS: The diagnostic yields from genome wide CNV analysis and whole exome sequence analysis are high - in the region of 15 and 40%, respectively - but vary according to exact referral criteria. Many variants pathogenic for intellectual disability, notably certain recurrent CNVs, have emerged as strong risk factors for other neurodevelopmental disorders such as autism spectrum disorders, attention deficit hyperactivity disorder, and schizophrenia.
SUMMARY: It is now conceivable that etiological variants could be identified in the majority of children presenting with intellectual disability using next-generation sequencing based assays. However, challenges remain in assessment of the pathogenicity of variants, reporting of incidental findings in children and determination of prognosis, particularly in relation to psychiatric disorders.

Entities:  

Mesh:

Year:  2018        PMID: 30138136     DOI: 10.1097/YCO.0000000000000456

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.787


  8 in total

1.  Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes.

Authors:  Kirsi S Oldenburg; T Michael O'Shea; Rebecca C Fry
Journal:  Semin Fetal Neonatal Med       Date:  2020-05-15       Impact factor: 3.926

2.  Shared Neurodevelopmental Perturbations Can Lead to Intellectual Disability in Individuals with Distinct Rare Chromosome Duplications.

Authors:  Thiago Corrêa; Cíntia B Santos-Rebouças; Maytza Mayndra; Albert Schinzel; Mariluce Riegel
Journal:  Genes (Basel)       Date:  2021-04-23       Impact factor: 4.096

3.  Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability.

Authors:  Alejandro J Brea-Fernández; Miriam Álvarez-Barona; Jorge Amigo; María Tubío-Fungueiriño; Pilar Caamaño; Montserrat Fernández-Prieto; Francisco Barros; Silvia De Rubeis; Joseph Buxbaum; Ángel Carracedo
Journal:  Eur J Hum Genet       Date:  2022-03-23       Impact factor: 5.351

4.  Descriptive Study of Transgender Youth Receiving Health Care in the Gender Identity Program in Southern Brazil.

Authors:  Bianca Machado Borba Soll; Anna Martha Fontanari; Angelo Brandelli Costa; Ítala Chinazzo; Dhiordan Cardoso Silva; Fernanda Guadagnin; Silzá Tramontina; Maria Inês Rodrigues Lobato
Journal:  Front Psychiatry       Date:  2021-03-04       Impact factor: 4.157

5.  Need for psychiatric phenotyping in patients with rare genetic disorders.

Authors:  Franziska Degenhardt; Gertraud Gradl-Dietsch; Johannes Hebebrand
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-03       Impact factor: 4.785

6.  Complex Diagnostics of Non-Specific Intellectual Developmental Disorder.

Authors:  Olga Levchenko; Elena Dadali; Ludmila Bessonova; Nina Demina; Galina Rudenskaya; Galina Matyushchenko; Tatiana Markova; Inga Anisimova; Natalia Semenova; Olga Shchagina; Oxana Ryzhkova; Rena Zinchenko; Varvara Galkina; Victoria Voinova; Sabina Nagieva; Alexander Lavrov
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

7.  Next-generation gene panel testing in adolescents and adults in a medical neuropsychiatric genetics clinic.

Authors:  Y Trakadis; A Accogli; B Qi; D Bloom; R Joober; E Levy; K Tabbane
Journal:  Neurogenetics       Date:  2021-08-07       Impact factor: 2.660

8.  Intellectual disability and nutrition-related health.

Authors:  Svein O Kolset
Journal:  EMBO Mol Med       Date:  2020-08-19       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.